GLP1 & CKD

Kidney Commute
06/09/2024 24 min Episodio 25
GLP1 & CKD

Listen "GLP1 & CKD"

Descargar episodio Ver en sitio original

Episode Synopsis

In this episode of the Kidney Commute podcast, panelists delve into the role of glucagon-like peptide-1 (GLP-1) receptor agonists in chronic kidney disease. The discussion explores the mechanisms of GLP-1 receptor agonists, their benefits in managing both kidney disease and related comorbidities like diabetes and cardiovascular disease, and the latest evidence supporting their use. Panelists also address practical challenges faced by both patients and providers.
 
Click here to claim CE Credit. 

More episodes of the podcast Kidney Commute

Pitstop: Uromodulin 13/12/2025
Pitstop: Part 2: Obesity in the Nephrology Clinic – Treatment and Management Principles 01/12/2025
Pitstop: Part 1: Obesity in the Nephrology Clinic – Risks, Roles, and Real-World Strategies 01/12/2025
Pitstop: Can a Nephrologist Say "No" to Dialysis? 13/10/2025
Pitstop: Applying eGFR Trends to Clinical Practice when Treating Patients with IgAN 02/10/2025
Benefits of Medical Nutrition Therapy (MNT) 22/09/2025
Pitstop: The Nephrologist’s Perspective in Evaluation and Management of Localized Renal Masses: Core Curriculum 2025 11/09/2025
Pitstop: Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2025 27/08/2025
Vascular Access and Home Hemodialysis 12/08/2025
Pitstop: Continuous Kidney Replacement Therapies from the Core Curriculum 2025 29/07/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA